The CDC is now asking prenatal care providers to warn their patients about potential nirsevimab supply shortages, with the hope that driving up the maternal vaccination rate could help ease the demand for nirsevimab.
RSV vaccine
FDA Panel Backs Pfizer RSV Vaccine for Pregnant Patients
Update: The FDA approved the vaccine for prevention of RSV in newborns on Aug. 21, 2023. Pfizer’s vaccine designed to…
FDA’s approval of the world’s first vaccine against RSV will offer a new tool in an old fight
The U.S. Food and Drug Administration approved the world’s first vaccine to prevent the respiratory infection RSV, short for respiratory…
FDA’s greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus
With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV,…
Timing and Cost of New Vaccines Vary by Virus and Health Insurance Status
Those who get one of the new RSV vaccines now should take a brief pause of at least two weeks before getting any other vaccination because there isn’t much data on whether they interact with other shots when received concurrently. Both covid and flu shots are worth getting, but it might be a good idea to wait a little bit.